Human Bone Marrow CD34+ Cells

Human Bone Marrow-derived CD34+ cells represent the gold standard for hematopoietic research, providing a powerful and clinically relevant model for hematopoiesis, immunology, and oncology. As multipotent stem cells capable of regenerating all blood lineages, these cells are the premier choice for researchers focused on bone marrow failure, leukemia modeling, and the development of advanced cell and gene therapies.

• Exceptional Multipotency and Self-Renewal: Our CD34+ cells exhibit high regenerative potential, capable of differentiating into erythroid, myeloid, and lymphoid lineages. This makes them an ideal platform for Colony-Forming Unit (CFU) assays and long-term culture-initiating cell (LTC-IC) studies.
• Superior Purity and Viability: Utilizing state-of-the-art immunomagnetic separation (MACS) technology, we guarantee a purity of ≥95% CD34+ cells. Each lot is rigorously screened for viability and post-thaw recovery, ensuring that your downstream experiments-from CRISPR/Cas9 gene editing to CAR-T development-start with the highest quality raw material.
• Clinically Relevant Benchmarking: Sourced from healthy human donors under strict ethical guidelines, these bone marrow-derived cells provide the "native" physiological baseline necessary for validating hematotoxicity in drug discovery pipelines, offering more predictive data than cord blood or mobilized peripheral blood in certain bone marrow niche studies.
• Ready-to-Use Functional Performance: Validated for rapid expansion and efficient engraftment in humanized mouse models, our CD34+ cells streamline your R&D timeline by providing consistent, high-performance results across diverse applications.

By integrating our highly purified Human Bone Marrow CD34+ cells into your workflow, you leverage a reliable and scalable biological system designed to accelerate breakthroughs in hematological sciences and regenerative therapeutics.